The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
Abby Jones’ first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. “Come in!” yelled ...
FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.
"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
Discover why UnitedHealth Group (UNH) could present a double-digit capital appreciation opportunity despite market pessimism ...
The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...
UnitedHealth, the biggest insurance company in America, is receiving backlash after an FTC report revealed that it was ...
A bill filed Thursday (Jan. 16) in the Arkansas Legislature would prohibit pharmacy benefit managers and insurance companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback